Early COVID-19 research is riddled with poor methods and low-quality results − a problem for science the pandemic worsened but didn’t create

Pressure to ‘publish or perish’ and get results out as quickly as possible has led to weak study designs and shortened peer-review processes.

Dennis M. Gorman, Professor of Epidemiology and Biostatistics, Texas A&M University • conversation
Feb. 23, 2024 • ~10 min

Pandemic, war and environmental disaster push scientists to deliver quick answers – here's what it takes to do good science under pressure

Scientists can be asked to help find solutions during disasters. A study of how archaeologists worked on the problem of looting during the Syrian war offers lessons for science done during crisis.

Michelle D. Fabiani, Assistant Professor of Criminal Justice, University of New Haven • conversation
Dec. 14, 2021 • ~8 min

One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19

Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.

Dimiter Stanchev Dimitrov, Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh • conversation
Oct. 1, 2020 • ~9 min

/

1